GoodRx Holdings (GDRX) Return on Capital Employed (2020 - 2026)

GoodRx Holdings' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 9.15% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 254.0% year-over-year to 9.15%; the TTM figure through Mar 2026 stood at 9.15% (up 254.0% YoY), while the FY2025 annual figure was 7.61%, up 278.0% from the prior year.
• Return on Capital Employed came in at 9.15% for Q1 2026 at GoodRx Holdings, up from 7.82% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 9.15% in Q1 2026 to a low of 2.2% in Q1 2024.
• A 5-year average of 2.69% and a median of 2.26% in 2024 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed surged 2702 bps in 2022 and sank 315 bps in 2024, its largest moves.
• GoodRx Holdings' Return on Capital Employed stood at 0.12% in 2022, then sank by 1637 bps to 1.77% in 2023, then jumped by 398 bps to 5.28% in 2024, then soared by 48 bps to 7.82% in 2025, then grew by 17 bps to 9.15% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 9.15%, 7.82%, and 7.28% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison